Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135427) titled 'Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: University of Alabama at Birmingham
Condition:
Alpha 1-Antitrypsin
COPD
Antibody Deficiency
Intervention:
Biological: 20-valent pneumococcal conjugate vaccine
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: September 2025
Target Sample Size: 30
Countries of Recruitment:
United States
To know more, visit https://clinical...